TY  - GEN
AU  - Van der Wall,Sake J
AU  - Lopes,Renato D
AU  - Aisenberg,James
AU  - Reilly,Paul
AU  - van Ryn,Joanne
AU  - Glund,Stephan
AU  - Elsaesser,Amelie
AU  - Klok,Frederikus A
AU  - Pollack,Charles V
AU  - Huisman,Menno V
TI  - Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding
SN  - 1524-4539
PY  - 2019///1212
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - adverse effects
KW  - Anticoagulants
KW  - Dabigatran
KW  - Drug Substitution
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - epidemiology
KW  - Female
KW  - Follow-Up Studies
KW  - Gastrointestinal Hemorrhage
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Risk Assessment
KW  - United States
KW  - Venous Thromboembolism
KW  - drug therapy
KW  - Vitamin K
KW  - antagonists & inhibitors
N1  - Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1161/CIRCULATIONAHA.118.036710
ER  -